Co-founder and CTO

Chris is a precision fermentation trailblazer and one of the most influential scientists and renowned experts in the field of cellular agriculture globally. He is the scientific mastermind behind many of the technologies currently used in the field, including Onego Bio’s cutting-edge technology to produce egg white proteins via precision fermentation. The chosen technology is based on harnessing the fungi Trichoderma reesei for protein production and Chris believes this technology is superior because of its efficiency and productivity.

Prior to co-founding Onego Bio, Chris spent 15 years developing breakthrough precision fermentation platforms at VTT Technical Research Centre of Finland. He has extensive experience in recombinant protein production and has been working with numerous players in the cell ag field internationally to translate this knowledge to enable commercial scale production of animal-free proteins. 

Christopher has a PhD in Pharmaceutical Sciences from the University of Michigan (USA) and has done postdoctoral work in Harvard Medical School (USA) and University of Bern Medical School (CH). He has published 43 peer-reviewed publications (H-index 28 and 3100 citations), 3 book chapters, and 8 patents or patent application families.